<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=384506&amp;fmt=gif">
Skip to content
    April 20, 2020

    Collaborative Drug Discovery Response to COVID-19 Pandemic

     

    CDD Press Release Logo

    Collaborative Drug Discovery Response to COVID-19 Pandemic

    Burlingame, California —April 20, 2020—Collaborative Drug Discovery Inc. (CDD) is involved in multiple international COVID-19 Public Private Partnerships (PPP) focused on repurposing and new therapeutics discovery - primarily in secure data sharing and mining. For 16 years, CDD has supported neglected disease preclinical drug discovery (core data sharing), with CDD Vault. CDD has also developed unique technologies to streamline the creation of FAIR Meta Data (BioAssay Express), and most recently automated LIVE semantic data streams (BioHarmony). These newer technologies complement core data sharing in more structured computer readable formats with direct applications to COVID-19 drug repurposing analyses. As the data available explodes, these technologies help normalize the emerging facts and keep abreast of developments. In all cases, there is a free version for publicly shared data (including a COVID-19 data set) coupled to a commercial version working with private, sensitive data.

    CDD’s flagship product, CDD Vault, is used to manage chemical registration, structure-activity relationships (SAR), and securely scale collaborations. CDD Vault is a hosted database solution for secure management and sharing of biological and chemical data. It lets researchers for either humanitarian or commercial endeavors intuitively organize chemical structures and biological study data, and collaborate with internal or external partners through an easy to use web interface. To help fight misinformation, as early as January 28th, CDD has been updating the community on the scientific facts associated with the COVID-19 pandemic.

    For more information on how we can help you, please email us at info@collaborativedrug.com.

    About Collaborative Drug Discovery, Inc.

    CDD’s (www.collaborativedrug.com) flagship product, “CDD Vault®”, is used to manage chemical registration, structure-activity relationships (SAR), and securely scale collaborations. CDD Vault® is a hosted database solution for secure management and sharing of biological and chemical data. It lets you intuitively organize chemical structures and biological study data, and collaborate with internal or external partners through an easy to use web interface. Available modules within CDD Vault include Activity & Registration, Visualization, Inventory, and ELN.

    A complete list of more than 60 publications and patents from CDD can be found online on our resources page at https://www.collaborativedrug.com/publications-and-resources/.


    Media Contact: Jason Harris, Ph.D., Collaborative Drug Discovery, marketing@collaborativedrug.com.

    Tag(s): CDD Blog , News

    Other posts you might be interested in

    View All Posts
    CDD Blog
    9 min   April 19, 2024
    Drug Discovery Industry Roundup with Barry Bunin — April 19, 2024
    Read More
    CDD Blog
    2 min   April 19, 2024
    CDD Appoints Yasushi Hamagashira as Head of Sales and Marketing for Japan
    Read More
    Events
    24 min   April 19, 2024
    Recap of CDD 20th Anniversary UGM – South San Francisco 2024
    Read More